Breakthrough Properties is a life science real estate investment firm that leverages cross-sector collaboration to deliver environments that foster innovation and scientific breakthroughs. Our team is a first-of-its-kind collaboration in real estate development, which came together through a shared passion that combines Tishman Speyer’s global real estate platform with Bellco Capital’s industry-making biotechnology entrepreneurship to capitalize on the rapidly expanding — yet substantially under-supplied — life science real estate industry. With real estate expertise spanning four continents, Tishman Speyer has built an international reputation for both developing and operating world-class properties across the globe. Bellco Capital is an industry-renowned investment firm that builds, invests in, and supports companies with bold ambitions of exponential transformation in life sciences. The Breakthrough team works hand-in-hand with both Tishman Speyer’s global real estate platform and Bellco’s extensive life science network to gain key insights and local support across the company’s core markets.
Bright Instrument Co Limited is a privately owned UK-based business, who supply a range of quality microtomes, cryostats, freezing units and accessories.
With a longstanding reputation for quality and service, Bright Instruments is your premier choice for laboratory sectioning and cryo-sectioning solutions.
With a longstanding reputation for quality and service, Bright Instruments is your premier choice for laboratory sectioning and cryo-sectioning solutions.
Bristows works with leading clients from across the sectors and offers a true spectrum of legal expertise, both contentious and non-contentious. The range of our experience enables us to advise on everything from the precedent-setting to the purely procedural. The common thread in everything we do is our ability to combine both commercial and legal perspectives. For more than 170 years, the Bristows name has represented a rigorous intellectual approach to the law, as well as a practical understanding of the ever-changing demands of business.
Broken String Bioscience’s technology platform, INDUCE-seq™ , supports the development of cell and gene therapies that are safer by design. INDUCE-seq™, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes. The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs.
Bulb Laboratories are laboratory fit-out & refurbishment specialists and consultants with unmatched construction & engineering expertise. We serve Scientific, Healthcare, Technology and Education sectors and pride ourselves on a professional service, that is custom suited to you. . . At every stage, we seek to meet your business needs and deliver beyond your expectations.
No data available
No data available
Cambridge Clinical Laboratories (CCL) is proud to provide healthcare professionals worldwide, with the most advanced testing services from our UKAS accredited facilities in the heart of scientific development, Cambridge, UK. In addition, CCL offers the UK public the opportunity to access a range of tests to enable independent health management, available via our selected partners. Our experience is coupled with a rapidly growing portfolio of molecular and virology diagnostics, next generation sequencing, pharmacogenetic and patient profiling tests, all of which employ cutting-edge technology.
Cambridge Employment Law LLP is a boutique employment law practice, advising both employers and employees. Our size and the specialist nature of our practice mean that you will have a personal relationship with a lawyer who understands your business and cares about its success. Our advice is always commercial and pragmatic, based on our lawyers' many years of experience and technical expertise. Eleanor Freeman has a particular interest in the biomedical sector. Her familiarity with the common challenges facing start-ups and high growth companies is balanced with significant experience representing global pharmaceuticals in all employment-related matters.
Cambridge Enterprise is responsible for the commercialisation of intellectual property from the University of Cambridge. We work with members of the university to help them commercialise their research and provide consultancy services to the industry. We give vital support to early-stage companies, helping them develop innovative technology ventures which benefit society and the wider economy.